Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

During the Trading Day
37.46 +0.05 / +0.13%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
37.51 +0.05 / +0.13%
 
Volume: 48.5K

Today’s Trading

Previous close37.41
Today’s open37.19
Day’s range36.69 - 37.64
Volume7,801,988
Average volume (3 months)7,201,185
Market cap$55.8B
Dividend yield2.78%
Data as of 4:00pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)+18.58%
Earnings growth (this year)+0.56%
Earnings growth (next 5 years)+10.45%
Revenue growth (last year)+0.78%
P/E ratio22.3
Price/Sales3.31
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-1.34-4.46%
CELGCelgene+1.29+1.32%
VRXValeant Pharmaceutic...-6.96-7.21%
ALXNAlexion Pharmaceutic...-3.13-2.20%
Data as of 4:14pm ET, 02/08/2016

Financials

Next reporting dateApril 13, 2016
EPS forecast (this quarter)$0.39
Annual revenue (last year)$20.4B
Annual profit (last year)$2.7B
Net profit margin12.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Senior VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts

Partner Offers